A Study of Ixekizumab (LY2439821) in Chinese Participants With Moderate-to-Severe Plaque Psoriasis
Clinical trial NCT03364309 · COMPLETED
Trial details
- NCT number
- NCT03364309
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-26
- Primary completion
- 2020-06-04
- Enrollment
- 438
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.